Mesenchymal Stromal Cells, Ex Vivo Cultured

6 trials 3 recruiting Orphan designation

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

3 Recruiting

2 Completed trials

5 Sponsors

6 Countries

Phase III

Phase II/III

Phase II

Phase III: 1 Phase II/III: 1 Phase II: 4

Indications tested

Acute graft versus host disease 2 Multiple sclerosis 1 Alveolar bone defect 1

Sponsors using this IMP

Medac Gesellschaft fuer klinische Spezialprapaerate mbH 2 Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia 1 Fondazione IRCCS San Gerardo Dei Tintori 1 Helse Bergen HF 1 University of Bergen 1

All trials

6 total

Efficacy of cell therapy with allo-MSCs in patients with gvhd resistant to ruxolitinib second line therapy: a Phase IIB Clinical Trial - MSC… Pending

2025-523448-10-00 Phase II 1 country Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia
Use of stem cells for the treatment of traumatic brain injury. Multicenter, doubleblind, randomized with placebo phase II clinical trial. Recruiting

2024-516510-38-00 Phase II 1 country Fondazione IRCCS San Gerardo Dei Tintori
SMART-MS Recruiting

2023-510228-63-00 Phase II 1 country Helse Bergen HF
An experimental study in adults and adolescents who underwent stem cell transplantation and developed a Graft versus Host Disease after ster… Recruiting

2023-505737-26-00 Phase III 4 countries Medac Gesellschaft fuer klinische Spezialprapaerate mbH
Trial of efficacy and safety of MC0518 versus best available therapy in patients with steroid-refractory acute graft versus host disease Ended

2023-503952-28-00 Phase II 5 countries Medac Gesellschaft fuer klinische Spezialprapaerate mbH
A multicentre clinical trial: Alveolar bone augmentation using MSCs and biphasic calcium phosphate granules prior to dental implants (Behand… Ended

2024-517976-39-00 Phase II/III 2 countries University of Bergen

Showing 1–6 of 6 trials

← All drugs A–Z